Wednesday, March 05, 2025 | 11:07 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Lupin recalls more than 18,000 bottles of antibiotic drug in US market

The drug, cefdinir for oral suspension, has been manufactured by Lupin's Mandideep manufacturing facility in central India

Lupin
Premium

Representative image

Subhadip Sircar | Bloomberg
Drug maker Lupin Ltd is recalling more than 18,000 bottles of an antibiotic drug used to treat bacterial infections from the US market.

Lupin Pharmaceuticals Inc, the US unit of the Indian company, is recalling the drug due to a “complaint received of metal piece identified in the product bottle prior to the reconstitution,” according to information on the US Food and Drug Administration, or USFDA, website.

The drug, cefdinir for oral suspension, has been manufactured by Lupin’s Mandideep manufacturing facility in central India.

The USFDA has classified it as a Class-II recall, which is initiated when use of or

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in